Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 15

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 15
---
 2021 to 2023.

San Mateo, California

March 6, 2023

F-5

Day One Biopharmaceuticals, Inc.

Balance Sheets

(in thousands, except share and per share amounts)

    December 31,2024

    December 31,2023

    Assets

    Current assets:

    Cash and cash equivalents
     
    $
    124,968

    $
    230,784

    Short-term investments

    406,752

    135,563

    Accounts receivable, net

    13,876

    —

    Inventory

    3,321

    —

    Prepaid expenses and other current assets

    13,413

    8,927

    Total current assets

    562,330

    375,274

    Property and equipment, net

    2,285

    208

    Operating lease right-of-use asset

    2,422

    352

    Intangible assets, net

    15,630

    —

    Deposits and other long-term assets

    121

    214

    Total assets
     
    $
    582,788

    $
    376,048

    Liabilities and stockholders’ equity

    Current liabilities:

    Accounts payable
     
    $
    3,262

    $
    2,576

    Accrued expenses and other current liabilities

    68,625

    26,524

    Current portion of deferred revenue

    1,554

    —

    Current portion of operating lease liabilities

    10

    408

    Total current liabilities

    73,451

    29,508

    Long-term portion of deferred revenue

    3,233

    —

    Long-term portion of operating lease liabilities

    2,592

    —

    Other long-term liability

    761

    —

    Total liabilities

    80,037

    29,508

    Commitments and contingencies (Note 7)

    Stockholders’ equity:

    Common stock, $0.0001 par value; 500,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 101,116,162 and 87,227,132 shares issued and outstanding as of December